Business / Finance

RSS
AMN consolidated revenue increases 32% to $887M for full year 2011

AMN consolidated revenue increases 32% to $887M for full year 2011

Boston Scientific exercises option to acquire Cameron Health

Boston Scientific exercises option to acquire Cameron Health

GenMark Diagnostics fourth quarter revenues increase to $2.0M

GenMark Diagnostics fourth quarter revenues increase to $2.0M

PharmAthene revenue increases to $24.3M for year ended December 31, 2011

PharmAthene revenue increases to $24.3M for year ended December 31, 2011

CHS prices $1.0 billion senior notes offering

CHS prices $1.0 billion senior notes offering

U.S. Physical Therapy fourth quarter net revenues increase 13.8% to $60,678,000

U.S. Physical Therapy fourth quarter net revenues increase 13.8% to $60,678,000

PhotoMedex fourth quarter revenues increase 26% to $28.8M

PhotoMedex fourth quarter revenues increase 26% to $28.8M

Unigene fourth quarter net income increases to $4.4 million

Unigene fourth quarter net income increases to $4.4 million

Celgene acquires Avila Therapeutics

Celgene acquires Avila Therapeutics

Omega Protein fourth quarter revenues increase 46% to $62.8M

Omega Protein fourth quarter revenues increase 46% to $62.8M

Cantel second quarter net income increases 28% to $7,294,000

Cantel second quarter net income increases 28% to $7,294,000

Amylin prices public offering of 13,000,000 shares of common stock

Amylin prices public offering of 13,000,000 shares of common stock

Columbia Labs fourth quarter total net revenues decrease to $6.4M

Columbia Labs fourth quarter total net revenues decrease to $6.4M

Bellicum raises $20M in Series B financing

Bellicum raises $20M in Series B financing

Heborium first quarter sales increase 23%

Heborium first quarter sales increase 23%

Medtech acquires Camelot Healthcare Training Institute

Medtech acquires Camelot Healthcare Training Institute

Zalicus fourth quarter revenue decreases to $8.2 million

Zalicus fourth quarter revenue decreases to $8.2 million

Celldex fourth quarter net loss increases to $12.7 million

Celldex fourth quarter net loss increases to $12.7 million

Transgenomic fourth quarter total revenue increases 68% to $8.6M

Transgenomic fourth quarter total revenue increases 68% to $8.6M

Nuance enters definitive agreement to acquire Transcend

Nuance enters definitive agreement to acquire Transcend

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.